AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11468536 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus, corticosteroids, and 1 g of MMF daily (MMF-1 g group, n=79)
Number of subjects: 232
Study 11468536 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus, corticosteroids, and 2 g of MMF daily (MMF-2 g group, n=71)
Number of subjects: 232
Study 9780474 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 5 mg i.m. weekly for 24 months
Number of subjects: 42
Study 7933425 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 hours of surfactant per day
Number of subjects: 51
Study 7933425 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 hours of surfactant per day
Number of subjects: 51
Study 7933425 — intervention group
Group type: COMPARATOR
Intervention: 0.6% saline (12 hours per day)
Number of subjects: 51
Study 7933425 — intervention group
Group type: COMPARATOR
Intervention: 0.6% saline (24 hours per day)
Number of subjects: 51
Study 3145585 — intervention group
Group type: EXPERIMENTAL
Intervention: Bretschneider cardioplegic HTK solution (group I)
Number of subjects: 249
Study 3145585 — intervention group
Group type: COMPARATOR
Intervention: St. Thomas cardioplegic solution (group II)
Number of subjects: 249
Study 29463280 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 unit of platelet concentrate
Number of subjects: 0
Study 29463280 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic platelet transfusion
Number of subjects: 0
Study 27234930 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.3 mg and 0.5 mg monthly)
Number of subjects: 745
Study 23554353 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold stimulation in BAT
Number of subjects: 0
Study 23554353 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin stimulation in BAT
Number of subjects: 0
Study 23554353 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-induced glucose uptake after 5-month weight loss
Number of subjects: 0
Study 23554353 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of detectable BAT
Number of subjects: 0
Study 21056403 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate delivery
Number of subjects: 376
Study 21056403 — intervention group
Group type: COMPARATOR
Intervention: Deferred delivery
Number of subjects: 376
Study 18332474 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 5187
Study 18332474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5187
Study 17004564 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealant
Number of subjects: 66
Study 17004564 — intervention group
Group type: EXPERIMENTAL
Intervention: Refurbishing
Number of subjects: 66
Study 17004564 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair
Number of subjects: 66
Study 17004564 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement
Number of subjects: 66
Study 17004564 — intervention group
Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 66
Study 14616818 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium titanyl phosphate (KTP) vascular laser
Number of subjects: 2
Study 14616818 — intervention group
Group type: COMPARATOR
Intervention: Hyfrecator
Number of subjects: 2
Study 14616818 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 2
Study 14616818 — intervention group
Group type: EXPERIMENTAL
Intervention: KTP vascular laser
Number of subjects: 2
Study 10808206 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg/day p. o. or i.v.)
Number of subjects: 355
Study 10808206 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B (0.2 mg/kg/day i.v.)
Number of subjects: 355
Study 10808206 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole and Amphotericin B
Number of subjects: 355
Study 8928757 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor I (IGF-I, 10 micrograms.kg-1.h-1 sc) for 3 days
Number of subjects: 8
Study 8928757 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor I (IGF-I)
Number of subjects: 8
Study 8928757 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8
Study 1481646 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisuride (1.3 mg mean daily dose, range 0.2-2.4 mg)
Number of subjects: 20
Study 1481646 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (15 mg mean daily dose, range 3.75-30.0 mg)
Number of subjects: 20
Study 1481646 — intervention group
Group type: COMPARATOR
Intervention: Control (levodopa and anticholinergic treatment unchanged)
Number of subjects: 20
Study 29850971 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 99
Study 29850971 — intervention group
Group type: COMPARATOR
Intervention: Audio book
Number of subjects: 99
Study 29850971 — intervention group
Group type: COMPARATOR
Intervention: Control (sit quietly)
Number of subjects: 99
Study 27565858 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid alone (control)
Number of subjects: 30
Study 27565858 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 × 10(6) cultured autologous BM‐MSCs
Number of subjects: 30
Study 27565858 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 × 10(6) cultured autologous BM‐MSCs
Number of subjects: 30
Study 24284287 — intervention group
Group type: COMPARATOR
Intervention: TMP-SMX plus placebo
Number of subjects: 626
Study 24284287 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP-SMX plus doxycycline
Number of subjects: 626
Study 23885605 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Lingtai (GV 10) and Shendao (GV 11)
Number of subjects: 72
Study 23885605 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture at bilateral Xuanzhong (GB 39)
Number of subjects: 72
Study 20510289 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-exercise group (APE 2 times for 1 hr/wk)
Number of subjects: 60
Study 20510289 — intervention group
Group type: COMPARATOR
Intervention: Low-exercise group (APE 1 time for 1 hr/wk)
Number of subjects: 60
Study 19770412 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic alert for VTE prophylaxis recommendation
Number of subjects: 1
Study 16371612 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.5 mg.kg‐1 mixed with acetaminophen suspension
Number of subjects: 40
Study 16371612 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen alone (Control)
Number of subjects: 40
Study 14556543 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg per day for 8 weeks
Number of subjects: 101
Study 14556543 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg per day for 8 weeks
Number of subjects: 101
Study 14556543 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg per day for 8 weeks
Number of subjects: 101
Study 11524467 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.10 mg/day of 17 beta‐estradiol by skin patch
Number of subjects: 20
Study 11524467 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 20
Study 9170199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (ursodiol)
Number of subjects: 0
Study 8390287 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus therapy
Number of subjects: 159
Study 8390287 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) therapy
Number of subjects: 159
Study 8390287 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 159
Study 3568934 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglyceride (MCT)
Number of subjects: 6
Study 3568934 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain triglyceride (LCT)
Number of subjects: 6
Study 29855175 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-122 (120 or 240 mg every week)
Number of subjects: 240
Study 29855175 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-122 (120 mg every week)
Number of subjects: 240
Study 29855175 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-122 (240 mg every week)
Number of subjects: 240
Study 29855175 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg every other week)
Number of subjects: 240
Study 29855175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 27692642 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25‐1mm particle size (small particles)
Number of subjects: 10
Study 27692642 — intervention group
Group type: COMPARATOR
Intervention: 1‐2mm particle size (large particles)
Number of subjects: 10
Study 24629425 — intervention group
Group type: EXPERIMENTAL
Intervention: Afoxolaner (oral chewable formulation at a dose of 2.5mg/kg)
Number of subjects: 16
Study 22831890 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine/tetracaine patch (Rapydan)
Number of subjects: 90
Study 22831890 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous injection of lidocaine 1%
Number of subjects: 90
Study 20339141 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive-based intervention (vouchers for abstaining from smoking)
Number of subjects: 158
Study 20339141 — intervention group
Group type: COMPARATOR
Intervention: Control condition (vouchers independent of smoking status)
Number of subjects: 158
Study 19336497 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mug extra fine hydrofluoroalkane (HFA) beclometasone dipropionate twice daily
Number of subjects: 243
Study 19336497 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 243
Study 16437396 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET/CT fusion imaging
Number of subjects: 15
Study 16437396 — intervention group
Group type: COMPARATOR
Intervention: Conventional 2-mm thickness whole-body CT scan
Number of subjects: 15
Study 12897276 — intervention group
Group type: EXPERIMENTAL
Intervention: Office-based educational program
Number of subjects: 39
Study 12897276 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study 10506039 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg taken orally three times daily
Number of subjects: 200
Study 10506039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 8671376 — intervention group
Group type: EXPERIMENTAL
Intervention: Interceed applied to one ovary
Number of subjects: 21
Study 8671376 — intervention group
Group type: COMPARATOR
Intervention: Control ovary (no Interceed)
Number of subjects: 21
Study 8671376 — intervention group
Group type: EXPERIMENTAL
Intervention: Interceed and Control
Number of subjects: 21
Study 1667755 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclical transdermal oestradiol 0.05 mg per day
Number of subjects: 45
Study 1667755 — intervention group
Group type: COMPARATOR
Intervention: Oral conjugated equine oestrogens 0.625 mg per day
Number of subjects: 45
Study 7059440 — intervention group
Group type: EXPERIMENTAL
Intervention: New osmotic pressure mediated delivery system for metoprolol (Lopresor Oros)
Number of subjects: 0
Study 7059440 — intervention group
Group type: COMPARATOR
Intervention: Commercial slow-release preparation (Slow Lopresor)
Number of subjects: 0
Study 31626166 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (chondroguard)
Number of subjects: 315
Study 31626166 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lower back pain syndrome)
Number of subjects: 315
Study 28423145 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy (BBT) - 8 to 12 weekly 45-minute sessions delivered by master's-level clinicians.
Number of subjects: 185
Study 28423145 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy (BBT)
Number of subjects: 185
Study 28423145 — intervention group
Group type: COMPARATOR
Intervention: Assisted Referral to Care (ARC)
Number of subjects: 185
Study 25876224 — intervention group
Group type: EXPERIMENTAL
Intervention: PEMFs application (I-ONE group)
Number of subjects: 68
Study 25876224 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (placebo group)
Number of subjects: 68
Study 24165545 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment with adjunctive slow-release dexamethasone implant
Number of subjects: 140
Study 24165545 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 140
Study 21378011 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 60
Study 19056646 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (714 mg/d GTP), 6 capsules per day for 3 weeks
Number of subjects: 33
Study 19056646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 17365528 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression stockings (pressure at ankle 18 - 22 mmHg)
Number of subjects: 28
Study 17365528 — intervention group
Group type: COMPARATOR
Intervention: Control (ankle-length sports socks only)
Number of subjects: 28
Study 12648190 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 438
Study 12648190 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anaesthesia
Number of subjects: 438
Study 12648190 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia (excluding patients who did not receive allocated anaesthetic)
Number of subjects: 438
Study 12648190 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (excluding patients who did not receive allocated anaesthetic)
Number of subjects: 438
Study 10719615 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release capsule of UDCA
Number of subjects: 0
Study 10719615 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release preparation of UDCA
Number of subjects: 0
Study 9187172 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-SK (chest tube pleural drainage plus streptokinase)
Number of subjects: 20
Study 9187172 — intervention group
Group type: COMPARATOR
Intervention: VATS (video-assisted thoracoscopic surgery)
Number of subjects: 20
Study 1540063 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL of 0.25% bupivacaine
Number of subjects: 40
Study 1540063 — intervention group
Group type: COMPARATOR
Intervention: 20 mL of 0.9% saline solution
Number of subjects: 40
Study 2881428 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 80
Study 2881428 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 80
Study 2881428 — intervention group
Group type: COMPARATOR
Intervention: Bromazepam and Thioridazine
Number of subjects: 80
Study 2881428 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy and Drug Treatment
Number of subjects: 80
Study 29608672 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCEPt intervention (multifaceted intervention to increase chlamydia testing)
Number of subjects: 44
Study 29608672 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly feedback (component of the ACCEPt intervention)
Number of subjects: 44
Study 30088707 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound amino acid plus vitamin E
Number of subjects: 120
Study 30088707 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E only
Number of subjects: 120
Study 25419768 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (CHG) cloths, used to clean skin 3 times per week for 6 months
Number of subjects: 4196
Study 25419768 — intervention group
Group type: COMPARATOR
Intervention: No skin treatment (Control group 3)
Number of subjects: 4196
Study 25419768 — intervention group
Group type: COMPARATOR
Intervention: Water cloths (Control group 2)
Number of subjects: 4196
Study 25419768 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (CHG) cloths
Number of subjects: 4196
Study 23181988 — intervention group
Group type: EXPERIMENTAL
Intervention: $20 incremental incentive group (n=30)
Number of subjects: 90
Study 23181988 — intervention group
Group type: EXPERIMENTAL
Intervention: $40 incremental incentive group (n=30)
Number of subjects: 90
Study 23181988 — intervention group
Group type: COMPARATOR
Intervention: No incentive control group (n=30)
Number of subjects: 90
Study 20547650 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive care program (9 home visits over the first year from a physiotherapist and a psychologist)
Number of subjects: 120
Study 20547650 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive care program
Number of subjects: 120
Study 20547650 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study 18606965 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 85 mg and naproxen sodium 500 mg (sumatriptan/naproxen)
Number of subjects: 1111
Study 18606965 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1111
Study 18606965 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan/naproxen
Number of subjects: 1111
Study 16015049 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-release propranolol (INP) dosed at 10 p.m.
Number of subjects: 44
Study 16015049 — intervention group
Group type: COMPARATOR
Intervention: Traditionally dosed propranolol (ILA) dosed at 8 a.m.
Number of subjects: 44
Study 12359798 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive disease management program
Number of subjects: 119
Study 10554688 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific inspiratory muscle training (SIMT)
Number of subjects: 20
Study 10554688 — intervention group
Group type: COMPARATOR
Intervention: Sham training (Control)
Number of subjects: 20
Study 8918511 — intervention group
Group type: COMPARATOR
Intervention: Diet + Exercise
Number of subjects: 219
Study 8918511 — intervention group
Group type: COMPARATOR
Intervention: Diet
Number of subjects: 219
Study 8918511 — intervention group
Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 219
Study 8918511 — intervention group
Group type: COMPARATOR
Intervention: Subgroup analysis (good responders)
Number of subjects: 219
Study 1683673 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin trihydrate
Number of subjects: 518
Study 1683673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study 6791197 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 11-2465 (1 mg daily for 3 days, then 3 mg daily for 7 days)
Number of subjects: 6
Study 6791197 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 11-2465 (after drug withdrawal)
Number of subjects: 6
Study 31939691 — intervention group
Group type: COMPARATOR
Intervention: Turn-assist technologies (two different turn-assist hospital beds)
Number of subjects: 0
Study 31939691 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual turning
Number of subjects: 0
Study 30902690 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube (ETI)
Number of subjects: 2652
Study 30902690 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal tube (LT)
Number of subjects: 2652
Study 30902690 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine administration <10 min from EMS arrival
Number of subjects: 2652
Study 30902690 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine administration ≥10 min from EMS arrival
Number of subjects: 2652
Study 28218589 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual‐perceptual and haptic‐perceptual training program (12 sessions)
Number of subjects: 28
Study 28218589 — intervention group
Group type: COMPARATOR
Intervention: Conventional handwriting training
Number of subjects: 28
Study 25640368 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic use of JiSaiXin (G‐CSF) 150ug per day for three days after chemotherapy (Group A)
Number of subjects: 100
Study 25640368 — intervention group
Group type: COMPARATOR
Intervention: G‐CSF (JiSaiXin) after neutropenia (Group B)
Number of subjects: 100
Study 25138978 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS four-item depression scale
Number of subjects: 244
Study 25138978 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS four-item anxiety scale
Number of subjects: 244
Study 22067789 — intervention group
Group type: EXPERIMENTAL
Intervention: New tablet formulation containing 0.02 mg ethinylestradiol/3 mg drospirenone/0.451 mg levomefolate calcium
Number of subjects: 44
Study 22067789 — intervention group
Group type: COMPARATOR
Intervention: Ethinylestradiol/drospirenone tablet
Number of subjects: 44
Study 22067789 — intervention group
Group type: COMPARATOR
Intervention: Levomefolate calcium tablet
Number of subjects: 44
Study 19464609 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30
Study 19464609 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 30
Study 17226060 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsiflexion pedaling technique
Number of subjects: 11
Study 17226060 — intervention group
Group type: COMPARATOR
Intervention: Self-selected control position
Number of subjects: 11
Study 15224204 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary approach offered by the Western Negev Mobile Clinic Diabetes Program (WNMDCP) for 6 months.
Number of subjects: 437
Study 15224204 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment in control clinic for 6 months.
Number of subjects: 437
Study 11796283 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass mail recruitment technique
Number of subjects: 2931
Study 11796283 — intervention group
Group type: EXPERIMENTAL
Intervention: Newspaper recruitment technique
Number of subjects: 2931
Study 11796283 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical sources recruitment technique
Number of subjects: 2931
Study 11796283 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio recruitment technique
Number of subjects: 2931
Study 11796283 — intervention group
Group type: EXPERIMENTAL
Intervention: Newsletters recruitment technique
Number of subjects: 2931
Study 9675505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (CBT) with exposure and response prevention
Number of subjects: 101
Study 7926899 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 8
Study 7926899 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 8
Study 7926899 — intervention group
Group type: COMPARATOR
Intervention: Classic needle acupuncture
Number of subjects: 8
Study 7926899 — intervention group
Group type: COMPARATOR
Intervention: Laser acupuncture
Number of subjects: 8
Study 7926899 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 8